Abstract
Most age-related neurodegenerative diseases remain incurable owing to an incomplete understanding of the disease mechanisms. Several environmental and genetic factors contribute to disease onset, with human biological ageing being the primary risk factor. In response to acute cellular damage and external stimuli, somatic cells undergo state shifts characterized by temporal changes in their structure and function that increase their resilience, repair cellular damage, and lead to their mobilization to counteract the pathology. This basic cell biological principle also applies to human brain cells, including mature neurons that upregulate developmental features such as cell cycle markers or glycolytic reprogramming in response to stress. Although such temporary state shifts are required to sustain the function and resilience of the young human brain, excessive state shifts in the aged brain might result in terminal fate loss of neurons and glia, characterized by a permanent change in cell identity. Here, we offer a new perspective on the roles of cell states in sustaining health and counteracting disease, and we examine how cellular ageing might set the stage for pathological fate loss and neurodegeneration. A better understanding of neuronal state and fate shifts might provide the means for a controlled manipulation of cell fate to promote brain resilience and repair.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zhao, N. et al. Alzheimer’s risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron 106, 727–742 (2020).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Guo, J. et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal. Transduct. Target. Ther. 7, 391 (2022).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).
Berben, L., Floris, G., Wildiers, H. & Hatse, S. Cancer and aging: two tightly interconnected biological processes. Cancers 13, 1400 (2021).
Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565–581 (2019).
Calabrese, V., Butterfield, D. A. & Stella, A. M. G. in Handbook of Neurochemistry and Molecular Neurobiology (eds Lajtha, A., Perez-Polo, J. R. & Rossner, S.) 103–146 (Springer, 2008).
Mattson, M. P. & Magnus, T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278–294 (2006).
Renthal, W. et al. Transcriptional reprogramming of distinct peripheral sensory neuron subtypes axonal injury. Neuron 108, 128–144 (2020).
Sofroniew, M. V. Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity. Trends Immunol. 41, 758–770 (2020).
Tan, C. L. et al. Warm-sensitive neurons that control body temperature. Cell 167, 47–59 (2016).
Suyama, S. et al. Glucose level determines excitatory or inhibitory effects of adiponectin on arcuate POMC neuron activity and feeding. Sci. Rep. 6, 30796 (2016).
Bano-Otalora, B. et al. Daily electrical activity in the master circadian clock of a diurnal mammal. Elife 10, e68179 (2021).
Poplawski, G. H. D. et al. Injured adult neurons regress to an embryonic transcriptional growth state. Nature 581, 77–82 (2020).
Guo, X.-J., Yang, D. & Zhang, X.-Y. Epigenetics recording varied environment and complex cell events represents the origin of cellular aging. J. Zhejiang Univ. Sci. B 20, 550–562 (2019).
Yang, J.-H. et al. Erosion of the epigenetic landscape and loss of cellular identity as a cause of aging in mammals. Preprint at bioRxiv https://www.biorxiv.org/content/10.1101/808642v1 (2019).
Wang, K. et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal. Transduct. Target. Ther. 7, 374 (2022).
Li, Y. & Tollefsbol, T. O. Age-related epigenetic drift and phenotypic plasticity loss: implications in prevention of age-related human diseases. Epigenomics 8, 1637–1651 (2016).
Yu, M., Hazelton, W. D., Luebeck, G. E. & Grady, W. M. Epigenetic aging: more than just a clock when it comes to cancer. Cancer Res. 80, 367–374 (2020).
Belmonte-Mateos, C. & Pujades, C. From cell states to cell fates: how cell proliferation and neuronal differentiation are coordinated during embryonic development. Front. Neurosci. 15, 1752 (2022).
Clevers, H. et al. What is your conceptual definition of “cell type” in the context of a mature organism? Cell Syst. 4, 255–259 (2017).
Morris, S. A., Klein, A. & Treutlein, B. The evolving concept of cell identity in the single cell era. Development 146, dev169748 (2019).
Viana, M. P. et al. Integrated intracellular organization and its variations in human iPS cells. Nature 613, 345–354 (2023).
Brandão, A. S. et al. A regeneration-triggered metabolic adaptation is necessary for cell identity transitions and cell cycle re-entry to support blastema formation and bone regeneration. Elife 11, e76987 (2022).
Urbán, N. & Cheung, T. H. Stem cell quiescence: the challenging path to activation. Development 148, dev165084 (2021).
Benninger, R. K. P. & Hodson, D. J. New understanding of β-cell heterogeneity and in situ islet function. Diabetes 67, 537–547 (2018).
Eban-Rothschild, A., Appelbaum, L. & de Lecea, L. Neuronal mechanisms for sleep/wake regulation and modulatory drive. Neuropsychopharmacol 43, 937–952 (2017).
Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).
Trapnell, C. Defining cell types and states with single-cell genomics. Genome Res. 25, 1491–1498 (2015).
Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487 (2017).
Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253–271 (2019).
Kole, A. J., Annis, R. P. & Deshmukh, M. Mature neurons: equipped for survival. Cell Death Dis. 4, e689 (2013).
Benn, S. C. & Woolf, C. J. Adult neuron survival strategies – slamming on the brakes. Nat. Rev. Neurosci. 5, 686–700 (2004).
Annis, R. P. et al. Mature neurons dynamically restrict apoptosis via redundant premitochondrial brakes. FEBS J. 283, 4569–4582 (2016).
Geloso, M. C. & D’Ambrosi, N. Microglial pruning: relevance for synaptic dysfunction in multiple sclerosis and related experimental models. Cells 10, 686 (2021).
Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458 (2011).
Lauro, C. & Limatola, C. Metabolic reprograming of microglia in the regulation of the innate inflammatory response. Front. Immunol. 11, 493 (2020).
Hou, J. et al. Heterogeneity analysis of astrocytes following spinal cord injury at single‐cell resolution. FASEB J. 36, e22442 (2022).
Olah, M. et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease. Nat. Commun. 11, 6129 (2020).
Deczkowska, A. et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073–1081 (2018).
Kamermans, A., Planting, K. E., Jalink, K., van Horssen, J. & de Vries, H. E. Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7-mediated chondroitin sulfate proteoglycan production. Glia 67, 68–77 (2019).
Guttenplan, K. A. et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun. 11, 3753 (2020).
Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 (1961).
van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014).
Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).
Burd, C. E. et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 152, 340–351 (2013).
Liu, J.-Y. et al. Cells exhibiting strong p16INK4a promoter activation in vivo display features of senescence. Proc. Natl Acad. Sci. USA 116, 2603–2611 (2019).
Fujimaki, K. et al. Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch. Proc. Natl Acad. Sci. USA 116, 22624–22634 (2019).
Liu, X.-L., Ding, J. & Meng, L.-H. Oncogene-induced senescence: a double edged sword in cancer. Acta Pharmacol. Sin. 39, 1553–1558 (2018).
Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119–1130 (2013).
Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436–453 (2018).
Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638–642 (2006).
Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat. Metab. 3, 1290–1301 (2021).
Sapieha, P. & Mallette, F. A. Cellular senescence in postmitotic cells: beyond growth arrest. Trends Cell Biol. 28, 595–607 (2018).
Sah, E. et al. The cellular senescence stress response in post-mitotic brain cells: cell survival at the expense of tissue degeneration. Life 11, 229 (2021).
Jurk, D. et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996–1004 (2012).
Riessland, M. et al. Loss of SATB1 induces p21-dependent cellular senescence in post-mitotic dopaminergic neurons. Cell Stem Cell 25, 514–530 (2019).
Musi, N. et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17, e12840 (2018).
Dehkordi, S. K. et al. Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology. Nat. Aging 1, 1107–1116 (2021).
Schwab, N., Leung, E. & Hazrati, L.-N. Cellular senescence in traumatic brain injury: evidence and perspectives. Front. Aging Neurosci. 13, 742632 (2021).
Paramos-de-Carvalho, D. et al. Targeting senescent cells improves functional recovery after spinal cord injury. Cell Rep. 36, 109334 (2021).
Herdy, J. R. et al. Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease. Cell Stem Cell 29, 1637–1652 (2022).
Moreno-Blas, D. et al. Cortical neurons develop a senescence-like phenotype promoted by dysfunctional autophagy. Aging 11, 6175–6198 (2019).
Chow, H.-M. et al. Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence. Nat. Neurosci. 22, 1806–1819 (2019).
Klass, M. R. Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span. Mech. Ageing Dev. 6, 413–429 (1977).
McCay, C. M., Crowell, M. F. & Maynard, L. A. The effect of retarded growth upon the length of life span and upon the ultimate body size: one figure. J. Nutr. 10, 63–79 (1935).
Johnson, T. E. & Wood, W. B. Genetic analysis of life-span in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 79, 6603–6607 (1982).
Zainabadi, K. A brief history of modern aging research. Exp. Gerontol. 104, 35–42 (2018).
Macchiarini, F., Miller, R. A., Strong, R., Rosenthal, N. & Harrison, D. E. in Handbook of the Biology of Aging 9th edn (eds Musi, N., Hornsby, P. J.) 219–235 (Elsevier, 2021).
Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).
Kennedy, B. K., Austriaco, N. R., Zhang, J. & Guarente, L. Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell 80, 485–496 (1995).
Fabrizio, P., Pozza, F., Pletcher, S. D., Gendron, C. M. & Longo, V. D. Regulation of longevity and stress resistance by Sch9 in yeast. Science 292, 288–290 (2001).
Campisi, J. et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183–192 (2019).
Teschendorff, A. E., West, J. & Beck, S. Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum. Mol. Genet. 22, R7–R15 (2013).
Zheng, S. C., Widschwendter, M. & Teschendorff, A. E. Epigenetic drift, epigenetic clocks and cancer risk. Epigenomics 8, 705–719 (2016).
Blanco, E., González-Ramírez, M., Alcaine-Colet, A., Aranda, S. & Di Croce, L. The bivalent genome: characterization, structure, and regulation. Trends Genet. 36, 118–131 (2020).
Enge, M. et al. Single-cell analysis of human pancreas reveals transcriptional signatures of aging and somatic mutation patterns. Cell 171, 321–330 (2017).
Li, Y. et al. A programmable fate decision landscape underlies single-cell aging in yeast. Science 369, 325–329 (2020).
White, M. C. et al. Age and cancer risk: a potentially modifiable relationship. Am. J. Prev. Med. 46, S7–S15 (2014).
Cao, Y. Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells. Cell Biosci. 7, 61 (2017).
Friedmann-Morvinski, D. & Verma, I. M. Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep. 15, 244–253 (2014).
Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193–1203 (2016).
Traxler, L. et al. Metabolism navigates neural cell fate in development, aging and neurodegeneration. Dis. Model. Mech. 14, dmm048993 (2021).
Martínez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669–680 (2021).
Vastenhouw, N. L. & Schier, A. F. Bivalent histone modifications in early embryogenesis. Curr. Opin. Cell Biol. 24, 374–386 (2012).
Bernhart, S. H. et al. Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer. Sci. Rep. 6, 37393 (2016).
Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39, 237–242 (2007).
Luth, H.-J. et al. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer’s disease brains. Cereb. Cortex 15, 211–220 (2004).
Duquette, A., Pernègre, C., Veilleux Carpentier, A. & Leclerc, N. Similarities and differences in the pattern of tau hyperphosphorylation in physiological and pathological conditions: impacts on the elaboration of therapies to prevent tau pathology. Front. Neurol. 11, 1823 (2021).
Hefti, M. M. et al. Tau phosphorylation and aggregation in the developing human brain. J. Neuropathol. Exp. Neurol. 78, 930–938 (2019).
Herrup, K. & Yang, Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat. Rev. Neurosci. 8, 368–378 (2007).
Mertens, J. et al. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients. Cell Stem Cell 28, 1533–1548 (2021).
Traxler, L. et al. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer’s disease. Cell Metab. 34, 1248–1263 (2022).
Gu, N. et al. DNA damage triggers reprogramming of differentiated cells into stem cells in Physcomitrella. Nat. Plants 6, 1098–1105 (2020).
Wagner, I. et al. Serum proteases potentiate BMP-Induced cell cycle re-entry of dedifferentiating muscle cells during newt limb regeneration. Dev. Cell 40, 608–617 (2017).
Oliva‐Vilarnau, N., Vorrink, S. U., Ingelman‐Sundberg, M. & Lauschke, V. M. A 3D cell culture model identifies Wnt/β‐catenin mediated inhibition of p53 as a critical step during human hepatocyte regeneration. Adv. Sci. 7, 2000248 (2020).
Van Haele, M., Snoeck, J. & Roskams, T. Human liver regeneration: an etiology dependent process. Int. J. Mol. Sci. 20, 2332 (2019).
Brilli Skvarca, L. et al. Enhancing regeneration after acute kidney injury by promoting cellular dedifferentiation in zebrafish. Dis. Model. Mech. 12, dmm037390 (2019).
Morrisey, E. E. Rewind to recover: dedifferentiation after cardiac injury. Cell Stem Cell 9, 387–388 (2011).
Meyer, A. R., Brown, M. E., Mcgrath, P. S. & Dempsey, P. J. Injury-induced cellular plasticity drives intestinal regeneration. Cell. Mol. Gastroenterol. Hepatol. 13, 843–856 (2022).
Yao, Y. & Wang, C. Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine. npj Regen. Med. 5, 14 (2020).
Kusaba, T., Lalli, M., Kramann, R., Kobayashi, A. & Humphreys, B. D. Differentiated kidney epithelial cells repair injured proximal tubule. Proc. Natl Acad. Sci. 111, 1527–1532 (2014).
Raya, Á. et al. Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc. Natl Acad. Sci. USA 100, 11889–11895 (2003).
Jhamb, D. et al. Network based transcription factor analysis of regenerating axolotl limbs. BMC Bioinforma. 12, 80 (2011).
Hayashi, S. et al. Epigenetic modification maintains intrinsic limb-cell identity in Xenopus limb bud regeneration. Dev. Biol. 406, 271–282 (2015).
Kragl, M. et al. Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature 460, 60–65 (2009).
Palla, A. R. et al. Primary cilia on muscle stem cells are critical to maintain regenerative capacity and are lost during aging. Nat. Commun. 13, 1439 (2022).
Carlson, M. E. & Conboy, I. M. Loss of stem cell regenerative capacity within aged niches. Aging Cell 6, 371–382 (2007).
Tower, R. J. et al. Spatial transcriptomics reveals metabolic changes underly age-dependent declines in digit regeneration. Elife 11, e71542 (2022).
Barrio-Alonso, E., Hernández-Vivanco, A., Walton, C. C., Perea, G. & Frade, J. M. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons. Sci. Rep. 8, 14316 (2018).
Caldwell, A. B. et al. Dedifferentiation and neuronal repression define familial Alzheimer’s disease. Sci. Adv. 6, eaba5933 (2020).
Manzo, E. et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife 8, e45114 (2019).
Ippati, S. et al. Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity. Proc. Natl Acad. Sci. USA 118, e2011876118 (2021).
Hong, X.-P. et al. Essential role of tau phosphorylation in adult hippocampal neurogenesis. Hippocampus 20, 1339–1349 (2010).
Kent, S. A., Spires-Jones, T. L. & Durrant, C. S. The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics. Acta Neuropathol. 140, 417–447 (2020).
Li, C. et al. Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury. Signal. Transduct. Target. Ther. 7, 65 (2022).
Ho, R. et al. ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks. Nat. Neurosci. 19, 1256–1267 (2016).
von Schimmelmann, M. et al. Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat. Neurosci. 19, 1321–1330 (2016).
Yang, Y. & Herrup, K. Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim. Biophys. Acta. 1772, 457–466 (2007).
Yang, Y., Geldmacher, D. S. & Herrup, K. DNA replication precedes neuronal cell death in Alzheimer’s disease. J. Neurosci. 21, 2661–2668 (2001).
Busser, J., Geldmacher, D. S. & Herrup, K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain. J. Neurosci. 18, 2801–2807 (1998).
Wilkens, R. et al. Diverse maturity-dependent and complementary anti-apoptotic brakes safeguard human iPSC-derived neurons from cell death. Cell Death Dis. 13, 887 (2022).
Wirth, M. et al. Alzheimer’s disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. J. Neurosci. 33, 5553–5563 (2013).
Herrup, K. Reimagining Alzheimer’s disease – an age-based hypothesis. J. Neurosci. 30, 16755–16762 (2010).
National Cancer Institute. Age and cancer risk. National Cancer Institute https://www.cancer.gov/about-cancer/causes-prevention/risk/age (2021).
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
Lapasset, L. et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248–2253 (2011).
Prigione, A., Fauler, B., Lurz, R., Lehrach, H. & Adjaye, J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28, 721–733 (2010).
Lo Sardo, V. et al. Influence of donor age on induced pluripotent stem cells. Nat. Biotechnol. 35, 69–74 (2017).
Miller, J. D. et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691–705 (2013).
Mertens, J. et al. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17, 705–718 (2015).
Ben-David, U. & Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11, 268–277 (2011).
Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719–1733 (2016).
Chondronasiou, D. et al. Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming. Aging Cell 21, e13578 (2022).
Lu, Y. et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature 588, 124–129 (2020).
Chen, Y. et al. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Science 373, 1537–1540 (2021).
Sarkar, T. J. et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat. Commun. 11, 1545 (2020).
Roux, A. E. et al. Diverse partial reprogramming strategies restore youthful gene expression and transiently suppress cell identity. Cell Syst. 13, 574–587 (2022).
Coyne, A. N. & Rothstein, J. D. Nuclear pore complexes – a doorway to neural injury in neurodegeneration. Nat. Rev. Neurol. 18, 348–362 (2022).
Anderson, S. R. et al. Neuronal apoptosis drives remodeling states of microglia and shifts in survival pathway dependence. Elife 11, e76564 (2022).
Roy, N. & Hebrok, M. Regulation of cellular identity in cancer. Dev. Cell 35, 674–684 (2015).
Andrés Blanco, M. et al. Chromatin-state barriers enforce an irreversible mammalian cell fate decision. Cell Rep. 37, 109967 (2021).
Ebert, A. D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2009).
Marchetto, M. C. N. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527–539 (2010).
Mertens, J., Marchetto, M. C., Bardy, C. & Gage, F. H. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat. Rev. Neurosci. 17, 424–437 (2016).
Frobel, J. et al. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep. 3, 414–422 (2014).
HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington’s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11, 264–278 (2012).
Schafer, S. T. et al. Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons. Nat. Neurosci. 22, 243–255 (2019).
Kim, Y. et al. Mitochondrial aging defects emerge in directly reprogrammed human neurons due to their metabolic profile. Cell Rep. 23, 2550–2558 (2018).
Victor, M. B. et al. Striatal neurons directly converted from Huntington’s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat. Neurosci. 21, 341–352 (2018).
Capano, L. S. et al. Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. Stem Cell 29, 918–932 (2022).
Luo, C. et al. Global DNA methylation remodeling during direct reprogramming of fibroblasts to neurons. Elife 8, e40197 (2019).
Acknowledgements
The authors thank A. Ocampo, S. Schäfer, P. Verstreken, B. De Strooper, I. Nitulescu, M. Wang and L. Karbacher for helpful discussions. The work of the authors is funded by the BrightFocus Foundation (A2019562S, A2022024F), the European Union (grants ERC-STG-2019-852086 and H2020-MSCA-IF-2017-797205), the Alzheimer Association (grant AARG-22-9723093), the Chen Foundation, the Austrian Science Fund (grant FWF-I5057), Clene Nanomedicine, the US National Academy of Medicine (NAM), the Michael J. Fox Foundation (MJFF), The National Institute on Aging (R01 grants AG05611, AG057706, AG072502, and AG056306, the K99-AG056679 and the P30-AG062429), the Paul G. Allen Frontiers Group (grant #19PABHI34610000), the Grace Foundation, the JPB Foundation, Annette C. Merle-Smith, Lynn and Edward Streim, the Ray and Dagmar Dolby Family Fund, the Milky Way Research Foundation, the Paul G. Allen Family Foundation, Stichting ASC Academy, California Institute for Regenerative Medicine (CIRM) (grant RT2–01927), the Austrian Marshall Plan Foundation, the Theodor Koerner Fonds, L’Oreal Austria/OeUK/OeAW Stipend, and the University of California, San Diego (UCSD).
Author information
Authors and Affiliations
Contributions
F.H.G., L.T., R.L., J.R.H., J.R.J, and J.M. researched data for the article. All authors contributed substantially to discussion of the content. All authors wrote the article. F.H.G., L.T., R.L., J.R.H., J.R.J. and J.M. reviewed and/or edited the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Neurology thanks M. Orr, A. Prigione and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Bivalent promoter chromatin marks
-
Activating and repressing histone modifications, such as histone 3 lysine 4 trimethylated (H3K4me3) and histone 3 lysine 27 trimethylated (H3K27me3).
- Cellular senescence
-
An irreversible damage response to intrinsic or extrinsic stimuli in normal cells, which results in diverse phenotypic alterations including cell cycle arrest, an inflammatory secretome, metabolic alterations and epigenetic reprograming.
- Epigenetic drift
-
Global stochastic deregulation of epigenetic patterns in response to environmental factors and ageing.
- Health span
-
The number of years lived when a person is healthy and free from disease.
- Metabolic drift
-
A change in preference for a set of specific metabolic pathways.
- Nuclear pore
-
A protein-lined channel in the nuclear envelope that regulates the transport of molecules, such as transcription factors, into and out of the nucleus.
- Proliferative arrest
-
The cessation of a cell proceeding through the cell cycle and dividing.
- Transcriptional noise
-
Variation in gene expression and transcriptional activity occurring among an otherwise homogeneous isogenic population of cells.
- Warburg effect
-
A metabolic switch from oxidative metabolism to aerobic glycolysis, first described in cancer cells.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Traxler, L., Lucciola, R., Herdy, J.R. et al. Neural cell state shifts and fate loss in ageing and age-related diseases. Nat Rev Neurol 19, 434–443 (2023). https://doi.org/10.1038/s41582-023-00815-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-023-00815-0
This article is cited by
-
Canalizing cell fate by transcriptional repression
Molecular Systems Biology (2024)